Phase 3 trials of vidofludimus calcium in relapsing MS enrolled
Enrollment is now complete in the twin Phase 3 clinical trials testing Immunic Therapeutics‘ oral small molecule vidofludimus…
Articles by Margarida Maia, PhD
BMI doesn’t affect response to stem cell transplant for MS
Body mass index (BMI), a measure commonly used measure of body fat based on a person’s height and weight, does…
Benefits of fenebrutinib in MS study sustained up to 2 years: Data
Almost two years of treatment with fenebrutinib — an investigational oral tablet for multiple sclerosis (MS) — helped…
Clinical tools can help detect early, subtle symptoms of MS: Study
While subtle symptoms of multiple sclerosis (MS) — like muscle weakness, fatigue, and numbness or unusual sensations — are…
MS patients in UK say they lack support to stay, thrive at work
Half of multiple sclerosis (MS) patients in the U.K. who work have compromised their health by staying in jobs…
Combined behavioral, cognitive training aids memory, coping skills
A 10-week program that combines cognitive behavioral therapy — a technique focused on understanding the connection between thoughts, feelings, and…
Placenta stem cells eased secondary progressive MS symptoms
Stem cells from donated placentas appear safe and may help reduce symptoms of secondary progressive multiple sclerosis (MS), according…
Ellagic acid supplements found to ease fatigue in MS in small trial
Three months of daily supplements containing ellagic acid — an antioxidant found naturally in many fruits and plants — significantly…
Non-drug interventions may improve sleep for MS patients
Non-pharmacological interventions such as mindfulness and exercise may improve sleep for people with multiple sclerosis (MS) while boosting overall…
Number of mitochondrial DNA copies tied to disease progression
As multiple sclerosis (MS) progresses, the disease may reduce the number of mitochondrial DNA copies, suggesting the number of…
Intrathecal methotrexate halts disability worsening, data show
Injections of methotrexate into the spinal canal given every three months were safe and well tolerated, and helped adults with…
Vidofludimus calcium lowers risk of progressive MS disability worsening
Vidofludimus calcium, an experimental oral therapy from Immunic Therapeutics, reduced the risk of confirmed disability worsening and slowed brain…
Younger, more severaly disabled SPMS patients have higher costs
The healthcare costs of secondary progressive multiple sclerosis (SPMS) are high, according to a real-world study in Spain, and…
Biostate AI, ACP to develop AI models to predict MS progression
Biostate AI is partnering with the nonprofit Accelerated Cure Project (ACP) to develop a series of artificial intelligence (AI)…
AAN 2025: Frexalimab results promising over 2-year extension
Frexalimab, an experimental antibody-based medication, was well tolerated and maintained disease control over two years in adults with relapsing forms…
AAN 2025: Real-world study of Briumvi for relapsing MS enrolling
A Phase 4 observational study called ENABLE is enrolling adults with relapsing forms of multiple sclerosis (MS) across the…
MS Canada’s annual MS Bike events set to roll out this summer
MS Canada is calling on everyone across Canada to tune up their bikes and join one of the many…
Copaxone appears safe for use in pregnancy, breastfeeding: Study
Treatment during pregnancy with the approved multiple sclerosis (MS) medication Copaxone (glatiramer acetate injection) does not appear to increase…
Quantum joins team to study PET tracer demyelination tracking
Quantum Biopharma is partnering with researchers at Massachusetts General Hospital in Boston on a clinical study to test a positron…
Study confirms approved Ocrevus dose as optimal for relapsing MS
No added benefit was found in increasing the dose of Genentech’s Ocrevus (ocrelizumab) — to two to three times…
AdventHealth recruiting for study of IDP-023 in progressive MS
The AdventHealth Neuroscience Institute is recruiting patients for a Phase 1b clinical trial testing IDP-023, an off-the-shelf cell-based treatment that…
Neurologist wins Dystel Prize for research on immune cells in MS
A researcher and neurologist at Penn Medicine in Philadelphia has won the 2025 John Dystel Prize for Multiple Sclerosis…
Bradley Cooper’s ‘Caregiving’ documentary on PBS this June
“Caregiving,” a two-hour documentary film centered on the daily experiences of six family and professional caregivers in the U.S.
Excess MS, autoimmune healthcare costs at $580K per 1K employees
For every 1,000 employees in the U.S., about $580,000 is spent each year in excess healthcare costs and lost work…
More Stamina app may help MS patients better manage fatigue
More Stamina, a gamified mobile app, helped a small group of people with multiple sclerosis (MS) better…
Walking function worse in Black MS patients than white patients
Black people with multiple sclerosis (MS) walk more slowly and cover shorter distances over a certain time period than…
Algorithm may reduce racial, ethnic inequalities in MS treatment: Study
Using a simple algorithm to recommend highly effective disease-modifying therapies (DMTs) for people with multiple sclerosis (MS) can…
Deescalating DMTs increases risk of disease activity in RRMS
People with multiple sclerosis (MS) who switch from a high- to a moderate-efficacy disease-modifying therapy (DMT) increase their…
Eating more fish linked to slower MS disability progression: Study
People with multiple sclerosis (MS) who eat more fish are significantly less likely to see confirmed disability progression and…
Delays of MS diagnosis in Finland reduced by half over last decade
Over the past decade, diagnoses of multiple sclerosis (MS) in Finland have become faster and treatments now follow the…